Skip to main content
Clinical Trials/NCT04013490
NCT04013490
Completed
Phase 1

Safety Evaluation and Effect of Food Supplement Containing Dietary Fiber From Cassava on the Alterations of Physiological Parameters in Overweight Female Volunteers

Khon Kaen University1 site in 1 country75 target enrollmentFebruary 27, 2019
ConditionsOverweight

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Overweight
Sponsor
Khon Kaen University
Enrollment
75
Locations
1
Primary Endpoint
The fasting blood sugar level
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study is set up to determine the consumption safety and the effect of a food supplement containing dietary fiber from cassava on the alterations of physiological parameters including fasting blood sugar, HbA1c, insulin resistance, lipid profiles, atherogenic index, blood pressure and gut microbes in overweight female volunteers.

Detailed Description

Cassava is one of the important industrial crops in Thailand. The leftover fiber of cassava is still valuable and can be used as a dietary fiber. The previous study demonstrated that dietary fiber containing cassava fiber was safe for consumption without any contamination of the cyanide and heavy metals. Moreover, the microbial contaminations were within the safety range. The toxicity study revealed that the LD50 of the cassava dietary fiber was more than 5 g/kg body weight (BW) and NOAEL was 3 g/kg BW. The NOAEL was used to calculate the human equivalent dose for determining the effect of cassava dietary fiber in a clinical study. Cassava dietary fiber consists of water-insoluble fiber such as cellulose more than 50%. The previous study showed that insoluble fiber decreased the risk of type 2 diabetes and increased insulin release. Moreover, a high fiber diet also decreased the fasting glucose and HbA1C in type 2 diabetes volunteer. In addition, the effect of dietary fiber on the reduction of cholesterol was also reported. The previous study reported that the cassava dietary fiber could decrease the total cholesterol, triglyceride but increase high-density lipoprotein in a dyslipidemia rat model. Therefore, the cassava fiber might be the potential food supplement for the control of blood sugar and lipid profiles in human. However, less scientific data support the effect of cassava dietary fiber in human.

Registry
clinicaltrials.gov
Start Date
February 27, 2019
End Date
August 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jintanaporn Wattanathorn

Associated Professor

Khon Kaen University

Eligibility Criteria

Inclusion Criteria

  • Healthy women age between 35-60 years old
  • BMI 23-29.99
  • Blood pressure \<140/90 mmHg
  • Fasting plasma glucose \< 100 mg/dL

Exclusion Criteria

  • Presence of any chronic diseases
  • Alcohol addict or consume more than 2 units/day
  • Smoking more than 10 cigarettes per day
  • Medication or herbal medicine usage within 1 month prior to the study
  • Use any medication or food supplement which affect to outcomes
  • Pregnant or breastfeeding women

Outcomes

Primary Outcomes

The fasting blood sugar level

Time Frame: Baseline and 4 weeks of intervention

The previous study reported that high dietary fiber could decrease the fasting blood sugar in type 2 diabetes patient. The overweight female volunteer receive food supplement containing dietary fiber from Cassava should show the lower level of fasting blood sugar than the placebo-treated group after 4 weeks of intervention.

The atherogenic index

Time Frame: 4 weeks of intervention

The atherogenic index is an index composed of triglycerides and high-density lipoprotein cholesterol. It has been used to quantify blood lipid levels and commonly used as an optimal indicator of dyslipidemia and associated diseases. The food supplement containing dietary fiber from Cassava might be able to decrease the atherogenic index in overweight female volunteer. The overweight female volunteer receive food supplement containing dietary fiber from Cassava should show the lower number of the atherogenic index than the placebo-treated group after 4 weeks of intervention.

Secondary Outcomes

  • Consumption safety of food supplement containing dietary fiber from Cassava using hematolgical values.(4 weeks of intervention)
  • hemoglobin A1c concentration(4 weeks of intervention)
  • Homeostasis model assessment-insulin resistance (HOMA-IR)(4 weeks of intervention)
  • Low-density lipoprotein (LDL) concentration(4 weeks of intervention)
  • High-density lipoprotein (HDL) concentration(4 weeks of intervention)
  • Triglyceride (TG) concentration(4 weeks of intervention)
  • Cholesterol concentration(4 weeks of intervention)
  • Body mass index (BMI)(4 weeks of intervention)
  • Gut microbes(4 weeks of intervention)
  • The consumption safety of food supplement containing dietary fiber from Cassava using Systolic and Diastolic Blood pressure(4 weeks of intervention)
  • The consumption safety of food supplement containing dietary fiber from Cassava using the electrocardiogram pattern and QT interval data(4 weeks of intervention)
  • Consumption safety of food supplement containing dietary fiber from Cassava using blood chemistry(4 weeks of intervention)

Study Sites (1)

Loading locations...

Similar Trials